Reaction
Periorbital Cellulitis reporting signals
As of the last recalculation, Periorbital Cellulitis appears in 528 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is AZACITIDINE FOR (PRR 45.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Azacitidine For | 20 | 45.0 | 45.1 |
| Mesna Injection | 8 | 38.7 | 38.8 |
| Mesna | 7 | 33.2 | 33.2 |
| Valganciclovir Hydrochloride Powder, | 10 | 32.9 | 33.0 |
| Azacitidine | 22 | 30.5 | 30.5 |
| Aprepitant | 10 | 21.7 | 21.8 |
| Ifosfamide | 11 | 20.6 | 20.6 |
| Pegaspargase | 6 | 19.5 | 19.5 |
| Botulinum Toxin Type A | 5 | 16.0 | 16.0 |
| Venetoclax | 23 | 15.3 | 15.4 |
| Lifitegrast | 5 | 12.2 | 12.2 |
| Bimekizumab | 5 | 9.3 | 9.3 |